The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 26, 2016

Filed:

Mar. 24, 2015
Applicant:

Cardiac Pacemakers, Inc., St. Paul, MN (US);

Inventors:

Jason J. Hamann, Blaine, MN (US);

Scott Vanderlinde, Plymouth, MN (US);

David J. Ternes, Roseville, MN (US);

Assignee:

Cardiac Pacemakers, Inc., St. Paul, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61N 1/378 (2006.01); A61N 1/37 (2006.01); A61N 1/372 (2006.01); A61N 1/39 (2006.01); A61B 5/00 (2006.01); H01M 10/48 (2006.01); H02J 7/00 (2006.01); G01R 31/36 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36142 (2013.01); A61N 1/3605 (2013.01); A61N 1/36139 (2013.01); A61N 1/36146 (2013.01); A61N 1/378 (2013.01); A61N 1/3708 (2013.01); A61N 1/3787 (2013.01); A61N 1/37276 (2013.01); A61N 1/3962 (2013.01); A61N 1/3975 (2013.01); A61B 5/0006 (2013.01); A61B 2560/0204 (2013.01); A61N 1/36053 (2013.01); G01R 31/3606 (2013.01); H01M 10/48 (2013.01); H02J 7/0047 (2013.01); H02J 7/0063 (2013.01); H02J 2007/005 (2013.01); H02J 2007/0067 (2013.01);
Abstract

An implantable medical device is powered by a battery to deliver one or more therapies including at least one non-life-sustaining therapy such as neural stimulation for enhancing quality of life of a patient. When the battery approaches its end of life, the implantable medical device reduces power consumption of the neural stimulation (e.g., intensity of the neural stimulation) for extending the remaining battery life while maintaining a certain amount of therapeutic benefits for the patient. In one embodiment, the intensity of the neural stimulation is reduced in a tiered manner. In one embodiment in which the implantable medical device also delivers at least one life-sustaining cardiac stimulation therapy, the neural stimulation is disabled or adjusted to reduce its power consumption (e.g., intensity) while the intensity of the cardiac stimulation therapy is maintained when the battery is near its end of life.


Find Patent Forward Citations

Loading…